Katie Thurston Shared Breast Cancer Treatment Update
Katie Thurston updated her treatment protocol and scheduled a new diagnostic scan following recent scan results.
Updated on Oct. 12, 2026 in Cancer
Katie Thurston has provided an update on her breast cancer treatment and monitoring status after a recent PET scan showed increased activity. The update comes as she prepares for further diagnostic imaging.
Why it matters
Changes in scan results can trigger adjustments in cancer management plans, necessitating further investigation to differentiate between inflammation and potential disease progression.
A recent PET scan, which identifies metabolic activity linked to inflammation or cancer, indicated increased light intensity on the right side of the body in a patient undergoing treatment for metastatic breast cancer. It remains unclear if this finding reflects new disease activity or exercise-induced inflammation.
The players
Katie Thurston
A patient managing metastatic breast cancer who shares updates regarding her treatment and diagnostic monitoring.
The details
Thurston is currently managed with quarterly ovarian suppression injections alongside an aromatase inhibitor and a CDK4/6 inhibitor. PET scans are used to monitor systemic disease, though findings like localized intensity can be confounded by physical activity prior to the exam. Thurston has previously undergone a double mastectomy and is currently monitored for elevated liver enzymes related to her therapy.
Timeline
February 2025: Katie Thurston was diagnosed with breast cancer.
March 2025: Doctors confirmed the cancer had spread to the liver.
April 2026: Thurston underwent a double mastectomy surgery.
September 2026: Thurston performed a chin liposuction procedure.
October 13, 2026: A follow-up FES scan is scheduled to be performed.
Health Landscape
Diagnostic imaging for metastatic breast cancer relies on the clinical use of PET scans to track disease status. Distinguishing between exercise-induced inflammation and cancer progression remains a critical challenge in routine patient monitoring.
Patients undergoing PET scans should discuss the impact of exercise and other lifestyle factors on potential scan artifacts with their oncology team. Any change in imaging results or the experience of treatment-related symptoms, such as elevated liver enzymes, should be reviewed with your doctor.
The takeaway
This case illustrates the complexity of monitoring metastatic cancer and the importance of follow-up scans when initial results are ambiguous. Always consult your oncology team to understand how specific activities or health markers may influence the results of your diagnostic imaging.
What happens next
Thurston is scheduled to undergo an FES scan on October 13, 2026, and plans to share the results of her imaging later in October 2026.
Further reading
Learn more about the latest developments in Cancer care and management.
Source note: This article includes information reported by Reality TV World.
